Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUNITINIB for Metastases to bone: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where SUNITINIB was used for Metastases to bone.

Most Reported Side Effects for SUNITINIB

Side Effect Reports % Deaths Hosp.
Disease progression 280 15.7% 44 36
Drug ineffective 243 13.6% 50 66
Malignant neoplasm progression 242 13.6% 80 32
Fatigue 132 7.4% 22 26
Diarrhoea 129 7.2% 24 38
Osteonecrosis of jaw 115 6.5% 2 8
Hypertension 99 5.6% 7 17
Off label use 99 5.6% 11 20
Thrombocytopenia 96 5.4% 21 35
Death 85 4.8% 83 6
Palmar-plantar erythrodysaesthesia syndrome 84 4.7% 7 13
Neutropenia 80 4.5% 15 15
Gastrointestinal stromal tumour 75 4.2% 25 8
Anaemia 74 4.2% 10 33
Nausea 69 3.9% 12 31

Other Indications for SUNITINIB

Gastrointestinal stromal tumour (297) Metastatic renal cell carcinoma (229) Product used for unknown indication (202) Renal cell carcinoma (143) Clear cell renal cell carcinoma (95) Renal cancer (80) Neoplasm malignant (56) Pancreatic neuroendocrine tumour (37) Pancreatic neuroendocrine tumour metastatic (29) Metastases to liver (27)

Other Drugs Used for Metastases to bone

DENOSUMAB (5,083) ZOLEDRONIC ACID (3,177) RADIUM RA-223 DICHLORIDE (1,501) PALBOCICLIB (556) CABOZANTINIB S-MALATE (514) ENZALUTAMIDE (439) XGEVA (412) RIBOCICLIB (383) LETROZOLE (263) CARBOPLATIN (254)

Related Pages

SUNITINIB Full Profile All Metastases to bone Drugs SUNITINIB Demographics SUNITINIB Timeline